arrow
Q

Quentin Bayard

Hadassah University Medical Center
H指数:15
被引数:1,658

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity

通过Visium、GeoMx DSP和Chromium对存档肿瘤进行转录组分析,揭示了患者异质性。

2025-05-120
OA
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target (vol 74, pg 1155, 2021)
2022-05-010
OA
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target

端粒长度是肝细胞癌多样性的关键,端粒酶成瘾是可行的治疗靶点

2021-05-0165
OAAI
Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer

整合基因组分析确定小儿肝癌的驱动基因和顺铂耐药祖细胞表型

2021-04-2326
OA
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA (vol 72, pg 924, 2020)
2020-07-010
OAAI
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response
2019-09-01147
OAAI
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma
2019-08-12148
PREAI
A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease

17-β-羟基类固醇脱氢酶13变体可防止酒精性肝病中肝细胞癌的发展

2019-04-2582
PREAI
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
2018-12-07121
OAAI
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis

突变特征揭示了肝肿瘤发生过程中危险因素和细胞过程的动态相互作用

2017-11-03213
OAAI